147 related articles for article (PubMed ID: 33015935)
21. Access to preventive care services and stage at diagnosis in head and neck cancer.
Farquhar DR; Lenze NR; Masood MM; Divaris K; Tasoulas J; Blumberg J; Lumley C; Patel S; Hackman T; Weissler MC; Yarbrough W; Zanation AM; Olshan AF
Head Neck; 2020 Oct; 42(10):2841-2851. PubMed ID: 32618052
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of Comorbidities among Older Head and Neck Cancer Survivors in the United States.
Eytan DF; Blackford AL; Eisele DW; Fakhry C
Otolaryngol Head Neck Surg; 2019 Jan; 160(1):85-92. PubMed ID: 30252608
[TBL] [Abstract][Full Text] [Related]
23. Analysis of patients who decline treatment for squamous cell carcinoma of the head and neck: National perspective.
Sullivan CB; Al-Qurayshi Z; Pagedar NA
Head Neck; 2020 Apr; 42(4):698-707. PubMed ID: 31895475
[TBL] [Abstract][Full Text] [Related]
24. Survival of patients with head and neck cancer treated with definitive radiotherapy and concurrent cisplatin or concurrent cetuximab: A Surveillance, Epidemiology, and End Results-Medicare analysis.
Xiang M; Holsinger FC; Colevas AD; Chen MM; Le QT; Beadle BM
Cancer; 2018 Dec; 124(23):4486-4494. PubMed ID: 30332498
[TBL] [Abstract][Full Text] [Related]
25. Clinical outcomes for patients presenting with N3 head and neck squamous cell carcinoma: Analysis of the National Cancer Database.
Ko HC; Chen S; Wieland AM; Yu M; Baschnagel AM; Hartig GK; Harari PM; Witek ME
Head Neck; 2017 Nov; 39(11):2159-2170. PubMed ID: 28737019
[TBL] [Abstract][Full Text] [Related]
26. Socioeconomic position and stage at diagnosis of head and neck cancer - a nationwide study from DAHANCA.
Olsen MH; Bøje CR; Kjær TK; Steding-Jessen M; Johansen C; Overgaard J; Dalton SO
Acta Oncol; 2015 May; 54(5):759-66. PubMed ID: 25734503
[TBL] [Abstract][Full Text] [Related]
27. Prevalence and clinical significance of cancer cachexia based on time from treatment in advanced-stage head and neck squamous cell carcinoma.
Kwon M; Kim RB; Roh JL; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
Head Neck; 2017 Apr; 39(4):716-723. PubMed ID: 28000343
[TBL] [Abstract][Full Text] [Related]
28. Analysis of palliative care treatment among head and neck patients with cancer: National perspective.
Sullivan CB; Al-Qurayshi Z; Chang K; Pagedar NA
Head Neck; 2021 Mar; 43(3):805-815. PubMed ID: 33151575
[TBL] [Abstract][Full Text] [Related]
29. Analysis of dysphagia in advanced-stage head-and-neck cancer patients: impact on quality of life and development of a preventive swallowing treatment.
Carmignani I; Locatello LG; Desideri I; Bonomo P; Olmetto E; Livi L; Le Saec O; Coscarelli S; Mannelli G
Eur Arch Otorhinolaryngol; 2018 Aug; 275(8):2159-2167. PubMed ID: 29978259
[TBL] [Abstract][Full Text] [Related]
30. Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definitive chemoradiotherapy.
Strongin A; Yovino S; Taylor R; Wolf J; Cullen K; Zimrin A; Strome S; Regine W; Suntharalingam M
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1823-30. PubMed ID: 21549516
[TBL] [Abstract][Full Text] [Related]
31. Impact of cisplatin dose intensity on human papillomavirus-related and -unrelated locally advanced head and neck squamous cell carcinoma.
Spreafico A; Huang SH; Xu W; Granata R; Liu CS; Waldron JN; Chen E; Ringash J; Bayley A; Chan KK; Hope AJ; Cho J; Razak AA; Hansen A; Jang R; Perez-Ordonez B; Weinreb I; Bossi P; Orlandi E; Licitra LF; Song Y; O'Sullivan B; Siu LL; Kim J
Eur J Cancer; 2016 Nov; 67():174-182. PubMed ID: 27669504
[TBL] [Abstract][Full Text] [Related]
32. High-dose or low-dose cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell cancer.
Chang CL; Yuan KS; Wu SY
Head Neck; 2017 Jul; 39(7):1364-1370. PubMed ID: 28370614
[TBL] [Abstract][Full Text] [Related]
33. Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis.
Iyer NG; Tan DS; Tan VK; Wang W; Hwang J; Tan NC; Sivanandan R; Tan HK; Lim WT; Ang MK; Wee J; Soo KC; Tan EH
Cancer; 2015 May; 121(10):1599-607. PubMed ID: 25639864
[TBL] [Abstract][Full Text] [Related]
34. Influence of Medicaid Expansion on Head and Neck Squamous Cell Carcinoma Presentation and Survival.
Arch RS; Fei-Zhang DJ; Patel U; Rastatter JC
Otolaryngol Head Neck Surg; 2024 Feb; 170(2):431-437. PubMed ID: 37811691
[TBL] [Abstract][Full Text] [Related]
35. Refusal of Cancer-Directed Surgery in Head and Neck Squamous Cell Carcinoma Patients.
Crippen MM; Elias ML; Weisberger JS; Brady JS; Eloy JA; Baredes S; Park RCW
Laryngoscope; 2019 Jun; 129(6):1368-1373. PubMed ID: 30070700
[TBL] [Abstract][Full Text] [Related]
36. Oral health in patients with different sites of head and neck squamous cell carcinoma is not different.
Kanzow P; Mielke K; Haupt F; Wiegand S; Schliephake H; Beutner D; Wiegand A
PLoS One; 2023; 18(10):e0293665. PubMed ID: 37883511
[TBL] [Abstract][Full Text] [Related]
37. Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients.
Descamps G; Karaca Y; Lechien JR; Kindt N; Decaestecker C; Remmelink M; Larsimont D; Andry G; Hassid S; Rodriguez A; Khalife M; Journe F; Saussez S
J Cancer Res Clin Oncol; 2016 Oct; 142(10):2185-96. PubMed ID: 27370781
[TBL] [Abstract][Full Text] [Related]
38. Differential impact of age on survival in head and neck cancer according to classic Cox regression and decision tree analysis.
Yang CC; Su YC; Lin YW; Huang CI; Lee CC
Clin Otolaryngol; 2019 May; 44(3):244-253. PubMed ID: 30578588
[TBL] [Abstract][Full Text] [Related]
39. Rigid Esophagoscopy for Head and Neck Cancer Staging and the Incidence of Synchronous Esophageal Malignant Neoplasms.
McGarey PO; O'Rourke AK; Owen SR; Shonka DC; Reibel JF; Levine PA; Jameson MJ
JAMA Otolaryngol Head Neck Surg; 2016 Jan; 142(1):40-5. PubMed ID: 26633039
[TBL] [Abstract][Full Text] [Related]
40. Impact of concomitant chemoradiation on survival for patients with T1-2N1 head and neck cancer.
Zumsteg ZS; Kim S; David JM; Yoshida EJ; Tighiouart M; Shiao SL; Scher K; Mita A; Sherman EJ; Lee NY; Ho AS
Cancer; 2017 May; 123(9):1555-1565. PubMed ID: 28001302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
